Want to join the conversation?
$TMO 1Q15 10-Q: Revenue: Life Sciences Solutions grew to $1.02Bil vs. 1Q14’s $836MM; Analytical Instruments $727MM vs. 1Q14’s $770MM; Specialty Diagnostics $785MM vs. 1Q14’s $814MM & Laboratory $1.51Bil vs. 1Q14’s $1.59Bil. Operating margin: Life Sciences Solutions 29.3%; Analytical Instruments16.7%; Specialty Diagnostics 27.3% & Laboratory 14.7%.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.